Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
. 2025 Mar 21;81(5):E149. doi: 10.1097/HEP.0000000000001262

Erratum: HDV RNA assays: Performance characteristics, clinical utility, and challenges

Heiner Wedemeyer, Mitchell Leus, Thomas R Battersby, Jeffrey Glenn, Emmanuel Gordien, Saleem Kamili, Hema Kapoor, Harald H Kessler, Oliver Lenz, Marc Lütgehetmann, Tonya Mixson-Hayden, Christian O Simon, Michael Thomson, Gabriel Westman, Veronica Miller, Norah Terrault, Pietro Lampertico, On behalf of the HDV RNA Assays Writing Group at the HBV Forum
PMCID: PMC12345792  PMID: 40127116

In the original article by Wedermeyer et al,1 Table 2 erroneously states that Bosphore HDV Quantification Detection Kit v1 is not calibrated to WHO international standards. This is incorrect. The manufacturer’s instructions for use state the following:

HDV Quantitation Standards were calibrated against the WHO 1st International Standard for Hepatitis D Virus RNA for NAT-based Assays Code 7657/12, by performing multiple assays using various dilutions and testing them in replicates. 1 IU was found to be equal to 3.63 copies/mL.

REFERENCE

  • 1. Wedemeyer H, Leus M, Battersby TR, Glenn J, Gordien E, Kamili S, et al. HDV RNA assays: Performance characteristics, clinical utility, and challenges. Hepatology. 2025;81:637–650. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Hepatology (Baltimore, Md.) are provided here courtesy of Wolters Kluwer Health

RESOURCES